durapatite has been researched along with hematoxylin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aretz, T; Brennan, JF; Dasari, RR; Feld, MS; Miller, A; Sacks, B; Salenius, JP; Wang, Y | 1 |
Artzi, Z; Dayan, D; Nemcovsky, CE; Tal, H | 1 |
Biewener, A; Petsch, E; Pompe, W; Rammelt, S; Schulze, E; Witt, M; Zwipp, H | 1 |
Develioglu, H; Kartal, U; Saraydin, S; Taner, L | 1 |
Bae, JH; Choi, KH; Kim, HJ; Kim, SE; Kim, SJ; Song, HR; Yang, JH; Yun, YP | 1 |
1 trial(s) available for durapatite and hematoxylin
Article | Year |
---|---|
Histopathological morphometric evaluation of 2 different hydroxyapatite-bone derivatives in sinus augmentation procedures: a comparative study in humans.
Topics: Absorbable Implants; Adult; Aged; Alveolar Ridge Augmentation; Animals; Biocompatible Materials; Bone Density; Bone Marrow; Bone Substitutes; Cattle; Coloring Agents; Dental Implants; Durapatite; Eosine Yellowish-(YS); Female; Fluorescent Dyes; Hematoxylin; Humans; Male; Maxillary Sinus; Middle Aged; Osseointegration; Osteocytes; Osteogenesis; Statistics as Topic; Wound Healing | 2001 |
4 other study(ies) available for durapatite and hematoxylin
Article | Year |
---|---|
Biochemical composition of human peripheral arteries examined with near-infrared Raman spectroscopy.
Topics: Arteriosclerosis; Calcinosis; Calcium; Carotid Arteries; Carotid Artery Diseases; Cholesterol; Coloring Agents; Coronary Disease; Coronary Vessels; Durapatite; Eosine Yellowish-(YS); Fatty Acids; Femoral Artery; Fluorescent Dyes; Foam Cells; Hematoxylin; Histocytochemistry; Humans; Peripheral Vascular Diseases; Reproducibility of Results; ROC Curve; Rupture, Spontaneous; Sensitivity and Specificity; Single-Blind Method; Spectroscopy, Near-Infrared; Spectrum Analysis, Raman | 1998 |
Collagen type I increases bone remodelling around hydroxyapatite implants in the rat tibia.
Topics: Animals; Biocompatible Materials; Biomarkers; Bone Remodeling; Bone Substitutes; Cathepsin D; Collagen Type I; Coloring Agents; Durapatite; Eosine Yellowish-(YS); Hematoxylin; Hyaluronan Receptors; Hydrogen-Ion Concentration; Immunohistochemistry; Implants, Experimental; Male; Osteoblasts; Osteonectin; Osteopontin; Phagocytes; Radiography; Rats; Rats, Wistar; Sialoglycoproteins; Surface Properties; Tibia; Time Factors | 2004 |
Evaluation of the long-term results of rat cranial bone repair using a particular xenograft.
Topics: Animals; Azo Compounds; Biocompatible Materials; Bone Diseases; Bone Matrix; Bone Regeneration; Bone Substitutes; Cattle; Collagen; Coloring Agents; Connective Tissue; Craniotomy; Durapatite; Eosine Yellowish-(YS); Fluorescent Dyes; Hematoxylin; Methyl Green; Osteoblasts; Osteoclasts; Osteocytes; Osteogenesis; Parietal Bone; Rats; Rats, Wistar; Time Factors; Transplantation, Heterologous | 2010 |
The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Topics: Analysis of Variance; Animals; Bone Morphogenetic Protein 2; Bony Callus; Calcium Phosphates; Collagen Type I; Drug Delivery Systems; Durapatite; Eosine Yellowish-(YS); Escherichia coli; Femur; Hematoxylin; Humans; Male; Microscopy, Electron, Scanning; Osteogenesis; Osteogenesis, Distraction; Osteopontin; Osteotomy; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Staining and Labeling; Time Factors; Transforming Growth Factor beta; X-Ray Microtomography | 2012 |